The global cancer vaccines market is entering a period of robust, sustained expansion — driven by a convergence of immunological breakthroughs, rising cancer incidence, and the accelerating adoption of precision medicine. According to the Cancer Vaccines Market report by MarketsandMarkets, valued at US$9.70 billion in 2023, the market climbed to US$9.84 billion in...